World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0017721929
Reproduction Date:

Title: Midafotel  
Author: World Heritage Encyclopedia
Language: English
Subject: Perzinfotel, Selfotel, Remacemide, Aptiganel, Para-Chlorophenylpiperazine
Publisher: World Heritage Encyclopedia


Systematic (IUPAC) name
(R)-4-[(E)- 3-phosphonoprop- 2-enyl]piperazine- 2-carboxylic acid
Pharmacokinetic data
Excretion Renal
CAS Registry Number  YesY
ATC code None
PubChem CID:
Synonyms CPPene, Midafotel, SDZ EAA 494
Chemical data
Formula C8H15N2O5P
Molecular mass 250.189 g/mol

Midafotel (CPPene; SDZ EAA 494) is a potent, competitive antagonist at the NMDA receptor.[1] It was originally designed as a potential therapy for excitotoxicity,[2] epilepsy or neuropathic pain.[3] It looked very promising in in vitro trials proving to be a potent competitive antagonist at the NMDA without affecting other receptors.[4] Research continued through to in vivo cat studies where it proved to limit damage after occluding the middle cerebral artery, leading to ischaemia. It also blocked photosensitive epilepsies in baboons.[5]

CPPene had a pharmacokinetic profile suitable for progressing to clinical trials, as it has no toxic by products, is excreted exclusively via the renal system, and remains unchanged in the brain.

However, CPPene was removed from clinical trials, as it provided no suitable neuronal protection or beneficial treatment for epilepsy,[6] and had side effects which led to many patients withdrawing from trials.[7] A possible explanation for its lack of efficacy in trials is the relatively short therapeutic time window following ischaemic damage and the fact that a small amount of glutamate helps neuronal survival. It is also believed that some "pro-survival" genes are activated by NMDA receptors.

See also


  1. ^ Lowe DA, Neijt HC, Aebischer B. D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801. Neuroscience Letters. 1990 Jun 8;113(3):315-21. PMID 2166255
  2. ^ Bullock R, McCulloch J, Graham DI, Lowe D, Chen MH, Teasdale GM. Focal ischemic damage is reduced by CPP-ene studies in two animal models. Stroke. 1990 Nov;21(11 Suppl):III32-6. PMID 2146780
  3. ^ Bespalov A, Kudryashova M, Zvartau E. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. European Journal of Pharmacology. 1998 Jun 26;351(3):299-305. PMID 9721021
  4. ^ Lowe DA, Emre M, Frey P, Kelly PH, Malanowski J, McAllister KH, Neijt HC, Rüdeberg C, Urwyler S, White TG, et al. The pharmacology of SDZ EAA 494, a competitive NMDA antagonist. Neurochemistry International. 1994 Dec;25(6):583-600. PMID 7894335
  5. ^ Patel S, Chapman AG, Graham JL, Meldrum BS, Frey P. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Epilepsy Research. 1990 Sep-Oct;7(1):3-10. PMID 2292244
  6. ^ Sveinbjornsdottir S, Sander JW, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS. The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Research. 1993 Oct;16(2):165-74. PMID 8269915
  7. ^ Rockstroh S, Emre M, Tarral A, Pokorny R. Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans. Psychopharmacology (Berlin). 1996 Apr;124(3):261-6. doi:10.1007/BF02246666 PMID 8740048
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.